101 related articles for article (PubMed ID: 9440717)
1. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
[TBL] [Abstract][Full Text] [Related]
2. Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.
Skórski T; Kawalec M; Kawiak J
Cancer Immunol Immunother; 1990; 32(1):71-4. PubMed ID: 2289201
[TBL] [Abstract][Full Text] [Related]
3. Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomas.
Nath SV; Prince HM; Choong PF; Toner GC
Int Semin Surg Oncol; 2005 May; 2(1):12. PubMed ID: 15927067
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter Study.
Kröger K; Siats J; Kerkhoff A; Lenz G; Stelljes M; Eich HT; Reinartz G
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765940
[TBL] [Abstract][Full Text] [Related]
5. Mantle Cell Lymphoma: Which Patients Should We Transplant?
Gerson JN; Barta SK
Curr Hematol Malig Rep; 2019 Aug; 14(4):239-246. PubMed ID: 31218478
[TBL] [Abstract][Full Text] [Related]
6. Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma.
Dahi PB; Lazarus HM; Sauter CS; Giralt SA
Bone Marrow Transplant; 2019 Jul; 54(7):943-960. PubMed ID: 30390059
[TBL] [Abstract][Full Text] [Related]
7. Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
Ye H; Desai A; Huang S; Jung D; Champlin R; Zeng D; Yan F; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2018 Jul; 37(1):150. PubMed ID: 30005678
[TBL] [Abstract][Full Text] [Related]
8. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
Atilla E; Atilla PA; Demirer T
Int J Hematol; 2017 Mar; 105(3):257-264. PubMed ID: 27995456
[TBL] [Abstract][Full Text] [Related]
9. The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?
Dreyling M; Ferrero S;
Haematologica; 2016 Feb; 101(2):104-14. PubMed ID: 26830211
[TBL] [Abstract][Full Text] [Related]
10. Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.
Cassaday RD; Guthrie KA; Budde EL; Thompson L; Till BG; Press OW; Chauncey TR; Pagel JM; Petersdorf SH; Palanca-Wessels MC; Philip M; Bensinger WI; Holmberg LA; Shustov A; Green DJ; Libby EN; Maloney DG; Gopal AK
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1403-6. PubMed ID: 23871782
[TBL] [Abstract][Full Text] [Related]
11. Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan.
Miura K; Takasaki H; Tsujimura H; Kanno M; Maeda Y; Tomita N; Takai K; Masaki Y; Takizawa J; Mori H; Terasaki Y; Yoshida T; Takeuchi J; Motomura S
Int J Hematol; 2011 May; 93(5):684-686. PubMed ID: 21479980
[No Abstract] [Full Text] [Related]
12. How I treat mantle cell lymphoma.
Straus DJ
J Oncol Pract; 2007 Sep; 3(5):281-2. PubMed ID: 20859426
[No Abstract] [Full Text] [Related]
13. Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.
Samad N; Younes A
Onco Targets Ther; 2010 Sep; 3():167-78. PubMed ID: 20856791
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Gressin R; Caulet-Maugendre S; Deconinck E; Tournilhac O; Gyan E; Moles MP; El Yamani A; Cornillon J; Rossi JF; Le Gouill S; Lepeu G; Damaj G; Celigny PS; Maisonneuve H; Corront B; Vilque JP; Casassus P; Lamy T; Colonna M; Colombat P;
Haematologica; 2010 Aug; 95(8):1350-7. PubMed ID: 20220059
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma in the elderly.
Caimi PF; Barr PM; Berger NA; Lazarus HM
Drugs Aging; 2010 Mar; 27(3):211-38. PubMed ID: 20210368
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.
Bogner C; Dechow T; Ringshausen I; Wagner M; Oelsner M; Lutzny G; Licht T; Peschel C; Pastan I; Kreitman RJ; Decker T
Br J Haematol; 2010 Jan; 148(1):99-109. PubMed ID: 19821820
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
Majhail NS; Bajorunaite R; Lazarus HM; Wang Z; Klein JP; Zhang MJ; Rizzo JD
Br J Haematol; 2009 Oct; 147(1):129-39. PubMed ID: 19573079
[TBL] [Abstract][Full Text] [Related]
18. Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
Till BG; Gooley TA; Crawford N; Gopal AK; Maloney DG; Petersdorf SH; Pagel JM; Holmberg L; Bensinger W; Press OW
Leuk Lymphoma; 2008 Jun; 49(6):1062-73. PubMed ID: 18452065
[TBL] [Abstract][Full Text] [Related]
19. Current management of mantle cell lymphoma.
Weigert O; Unterhalt M; Hiddemann W; Dreyling M
Drugs; 2007; 67(12):1689-702. PubMed ID: 17683170
[TBL] [Abstract][Full Text] [Related]
20. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
Nademanee A; Forman S; Molina A; Fung H; Smith D; Dagis A; Kwok C; Yamauchi D; Anderson AL; Falk P; Krishnan A; Kirschbaum M; Kogut N; Nakamura R; O'donnell M; Parker P; Popplewell L; Pullarkat V; Rodriguez R; Sahebi F; Smith E; Snyder D; Stein A; Spielberger R; Zain J; White C; Raubitschek A
Blood; 2005 Oct; 106(8):2896-902. PubMed ID: 16002426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
